IOM Steps into Transparency Debate, Seeks Comment on Data-Sharing Plan

Clinical Trials Advisor
While EU regulators push ahead with a trial transparency initiative, the Institute of Medicine has stepped into the debate, seeking feedback on a wide range of proposals to encourage clinical data sharing in the U.S.

To View This Article:


Subscribe To Clinical Trials Advisor

Buy This Article Now

Add this article to your cart for $25.00